TEMLAGDI

Bristol-Myers Squibb Company

Application Filed: 2017-06-22

Trademark Application Details

Status

732

Live/Pending

THIRD EXTENSION - GRANTED

Research	OneLook Acronym Finder
Serial Number	87501338
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Marilyn F. Kelly
Law Office Assigned	L40
Employee Name	FATHY, DOMINIC

Timeline

2017-06-22	Application Filed
2018-04-24	Published for Opposition
2018-06-19	Location: INTENT TO USE SECTION
2019-12-19	Status: Live/Pending
2019-12-21	Transaction Date

Trademark Applicants & Owners

Owner:	Bristol-Myers Squibb Company
Address	430 E. 29th Street, 14th Floor New York DE 10016
Legal Entity Type	Corporation
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

MARILYN F. KELLY
BRISTOL-MYERS SQUIBB COMPANY
TRADEMARKS DEPT., MAILSTOP B22-02
P.O. BOX 4000
PRINCETON NJ 08648-4000

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Type Code

Type

GS0051

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2017-06-26	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2017-06-29	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2017-09-18	3 DOCK D:Assigned to Examiner
PRIORITY ACTION WRITTEN	2017-09-19	4 CPRA R:Renewal
PRIORITY ACTION E-MAILED	2017-09-19	5 GPRA F:First Action
NOTIFICATION OF PRIORITY ACTION E-MAILED	2017-09-19	6 GPRN O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2018-03-19	7 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2018-03-19	8 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED	2018-03-20	9 TEME I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2018-03-22	10 CNSA P:
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2018-04-04	11 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2018-04-24	12 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2018-04-24	13 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2018-06-19	14 NOAM E:E-Mail
TEAS CHANGE OF OWNER ADDRESS RECEIVED	2018-10-08	15 COAR I:Incoming Correspondence
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED	2018-10-08	16 CHAN I:Incoming Correspondence
TEAS EXTENSION RECEIVED	2018-12-19	17 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2018-12-19	18 EXT1 S:
EXTENSION 1 GRANTED	2018-12-19	19 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2018-12-21	20 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2019-06-19	21 EEXT I:Incoming Correspondence
EXTENSION 2 FILED	2019-06-19	22 EXT2 S:
EXTENSION 2 GRANTED	2019-06-19	23 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2019-06-21	24 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2019-12-19	25 EEXT I:Incoming Correspondence
EXTENSION 3 FILED	2019-12-19	26 EXT3 S:
EXTENSION 3 GRANTED	2019-12-19	27 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2019-12-21	28 EXRA E:E-Mail
ABANDONMENT - NO USE STATEMENT FILED	2020-07-20	29 ABN6 S:
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED	2020-07-20	30 MAB6 E:E-Mail
TEAS PETITION TO REVIVE RECEIVED	2020-07-20	31 PROA I:Incoming Correspondence
PETITION TO REVIVE-GRANTED	2020-07-20	32 PETG O:Outgoing Correspondence
EXTENSION RECEIVED WITH TEAS PETITION	2020-07-20	33 TPEX I:Incoming Correspondence
NOTICE OF REVIVAL - E-MAILED	2020-07-21	34 NREV E:E-Mail
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2020-09-08	35 AITU A:Allowance for Publication
EXTENSION 4 FILED	2020-06-19	36 EXT4 S:
EXTENSION 4 GRANTED	2020-09-09	37 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2020-09-10	38 EXRA E:E-Mail
ABANDONMENT - NO USE STATEMENT FILED	2021-01-25	39 ABN6 S:
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED	2021-01-25	40 MAB6 E:E-Mail

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.